Which of the following ‘statins’ has the longest half life ?
**Core Concept**
The question is testing the pharmacokinetic properties of statins, specifically their half-lives. Statins are a class of lipid-lowering medications that inhibit HMG-CoA reductase, a key enzyme in cholesterol biosynthesis. Understanding the half-life of statins is crucial for determining their dosing frequency and potential for drug interactions.
**Why the Correct Answer is Right**
Atorvastatin has a relatively long half-life, which allows for once-daily dosing. Its half-life is approximately 14 hours, allowing it to maintain a stable plasma concentration over a 24-hour period. This is due to its extensive hepatic metabolism and significant plasma protein binding, which slows its elimination from the body.
**Why Each Wrong Option is Incorrect**
**Option A:** Lovastatin has a half-life of around 2-3 hours, making it one of the shortest-acting statins. Its short half-life requires more frequent dosing, which can be inconvenient for patients.
**Option B:** Simvastatin has a half-life of around 2-3 hours, similar to Lovastatin. Its short half-life also necessitates more frequent dosing, although it can be taken at bedtime to help maintain a steady plasma concentration.
**Option C:** Pravastatin has a half-life of around 2 hours, making it another short-acting statin. Its short half-life requires more frequent dosing, which can be a limitation for some patients.
**Clinical Pearl / High-Yield Fact**
When choosing a statin, consider the patient's lifestyle and medication regimen. Statins with longer half-lives, such as Atorvastatin, may be more convenient for patients who take their medication once daily. However, statins with shorter half-lives, such as Lovastatin and Simvastatin, may be more suitable for patients who require more frequent dosing.
**Correct Answer: C. Pravastatin has a half-life of around 2 hours, making it another short-acting statin. Its short half-life requires more frequent dosing, which can be a limitation for some patients.